Browsing by Author "Jelovac, Drago B. (58449716800)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Intraosseous focal venous malformation of the mandibular body: Cone beam computed tomography planning followed by piezoelectric knife resection and free bone graft reconstruction; [Intraosealna fokalna venska malformacija tela donje vilice: Planiranje piezoelektrične resekcije pomoću kompjuterizovane tomografije konusnim zrakom i rekonstrukcija slobodnim koštanim transplantatom](2017) ;Nikolić, Živorad S. (15023327100) ;Jelovac, Drago B. (58449716800) ;Šabani, Melvil (57191286326) ;Jeremić, Jelena V. (15022530400)Boričić, Ivan (6603959716)Introduction. Intraosseous vascular malformation could be life-threatening due to uncontrolled hemorrhage after tooth extraction. According to biological behavior of this lesion, adequate diagnostic and treatment strategies are necessary in order to avoid possible complications. We reported cone beam computed tomography (CBCT) planning of an urgent en bloc resection of an intraosseous venous malformation by piezoelectric knife. Case report. A 55-year-old man was submitted to CBCT planning followed by piezoelectric knife resection of an intraosseous focal venous malformation of the mandibular body. Immediate reconstruction of the defect using iliac bone free graft was performed. The surgical treatment was uneventful and a 2-year follow-up revealed no signs of recurrence. Conclusion. Piezoelectric knife could provide precise, safe and bloodless procedure which is especially important in this pathology. Advantages of this technique are: lower risk of damaging soft tissue structures, precise osteotomy and bloodless surgery. Moreover, using piezosurgery bone knife, blood transfusion and blood transmitted diseases could be avoided. This case highlights the importance of CBCT as planning tool for resection of the mandible, using piezoelectric knife as safe method to achieve bloodless surgery. © 2017, Institut za Vojnomedicinske Naucne Informacije/Documentaciju. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Modified Risdon approach using Periangular incision in surgical treatment of Subcondylar Mandibular fractures(2016) ;Nikolić, Živorad S. (15023327100) ;Jelovac, Drago B. (58449716800) ;Šabani, Melvil (57191286326)Jeremić, Jelena V. (15022530400)Introduction No consensus has been reached yet on the surgical approach for treatment of condylar fractures. Objective The aim of this study was to present modified Risdon approach (without facial nerve identification) in the treatment of subcondylar mandibular fractures. Method This is a retrospective study of a period 2005–2012. During this seven-year period, 25 condylar mandibular fractures in 22 men and three women (19–68 years old) were treated by modified Risdon approach without identifying the facial nerve. The main inclusion criterion was subcondylar fracture according to Lindahl classification. Results No additional morbidity related to postoperative complications, such as infection or salivary fistula, was observed in this series. Only two (8%) patients developed temporary weakness of the marginal branch of the facial nerve, which resolved six weeks postoperatively. Each patient achieved good mouth opening postoperatively. Scar was camouflaged in the first cervical wrinkle. Two patients developed temporomandibular joint dysfunction. No patient had postoperative occlusal disturbance. In all of the patients good aesthetic result was achieved in a two-year follow-up. Conclusion In comparison with techniques described in the literature, the main advantages of the modified Risdon approach are the following: no need for facial vessels identification; direct, fast, and safe approach to mandibular angle and subcondylar region; relatively simple surgical technique and good cosmetic result – due to aesthetically placed incision. This approach could be recommended for subcondylar fracture as a simplified and safe procedure. © 2016, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population(2011) ;Brinkmann, Ole (36627946300) ;Kastratovic, Dragana A. (9241792300) ;Dimitrijevic, Milovan V. (25642808400) ;Konstantinovic, Vitomir S. (6603379099) ;Jelovac, Drago B. (58449716800) ;Antic, Jadranka (36627982000) ;Nesic, Vladimir S. (6701399959) ;Markovic, Srdjan Z. (57210721043) ;Martinovic, Zeljko R. (57197574072) ;Akin, David (35783926300) ;Spielmann, Nadine (57210997989) ;Zhou, Hui (59804840900)Wong, David T. (7401535896)Early detection of oral squamous cell cancer (OSCC) is the key to improve the low 5-year survival rate. Using proteomic and genomic technologies we have previously discovered and validated salivary OSCC markers in American patients. The question arises whether these biomarkers are discriminatory in cohorts of different ethnic background. Six transcriptome (DUSP1, IL8, IL1B, OAZ1, SAT1, and S100P) and three proteome (IL1B, IL8, and M2BP) biomarkers were tested on 18 early and 17 late stage OSCC patients and 51 healthy controls with quantitative PCR and ELISA. Four transcriptome (IL8, IL1B, SAT1, and S100P) and all proteome biomarkers were significantly elevated (p < 0.05) in OSCC patients. The combination of markers yielded an AUC of 0.86, 0.85 and 0.88 for OSCC total, T1-T2, and T3-T4, respectively. The sensitivity/specificity for OSCC total was 0.89/0.78, for T1-T2 0.67/0.96, and for T3-T4 0.82/0.84. In conclusion, seven of the nine salivary biomarkers (three proteins and four mRNAs) were validated and performed strongest in late stage cancer. Patient-based salivary diagnostics is a highly promising approach for OSCC detection. This study shows that previously discovered and validated salivary OSCC biomarkers are discriminatory and reproducible in a different ethnic cohort. These findings support the feasibility to implement multi-center, multi-ethnicity clinical trials towards the pivotal validation of salivary biomarkers for OSCC detection. - Some of the metrics are blocked by yourconsent settings
Publication Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population(2011) ;Brinkmann, Ole (36627946300) ;Kastratovic, Dragana A. (9241792300) ;Dimitrijevic, Milovan V. (25642808400) ;Konstantinovic, Vitomir S. (6603379099) ;Jelovac, Drago B. (58449716800) ;Antic, Jadranka (36627982000) ;Nesic, Vladimir S. (6701399959) ;Markovic, Srdjan Z. (57210721043) ;Martinovic, Zeljko R. (57197574072) ;Akin, David (35783926300) ;Spielmann, Nadine (57210997989) ;Zhou, Hui (59804840900)Wong, David T. (7401535896)Early detection of oral squamous cell cancer (OSCC) is the key to improve the low 5-year survival rate. Using proteomic and genomic technologies we have previously discovered and validated salivary OSCC markers in American patients. The question arises whether these biomarkers are discriminatory in cohorts of different ethnic background. Six transcriptome (DUSP1, IL8, IL1B, OAZ1, SAT1, and S100P) and three proteome (IL1B, IL8, and M2BP) biomarkers were tested on 18 early and 17 late stage OSCC patients and 51 healthy controls with quantitative PCR and ELISA. Four transcriptome (IL8, IL1B, SAT1, and S100P) and all proteome biomarkers were significantly elevated (p < 0.05) in OSCC patients. The combination of markers yielded an AUC of 0.86, 0.85 and 0.88 for OSCC total, T1-T2, and T3-T4, respectively. The sensitivity/specificity for OSCC total was 0.89/0.78, for T1-T2 0.67/0.96, and for T3-T4 0.82/0.84. In conclusion, seven of the nine salivary biomarkers (three proteins and four mRNAs) were validated and performed strongest in late stage cancer. Patient-based salivary diagnostics is a highly promising approach for OSCC detection. This study shows that previously discovered and validated salivary OSCC biomarkers are discriminatory and reproducible in a different ethnic cohort. These findings support the feasibility to implement multi-center, multi-ethnicity clinical trials towards the pivotal validation of salivary biomarkers for OSCC detection.
